Kitagawa Kazuo, Yoshizawa Hiroshi, Toi Sono, Todo Kenichi
Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Departemnt of Neurology, Suita Municipal Hospital, Suita, Japan.
J Alzheimers Dis. 2025 Aug 6:13872877251365629. doi: 10.1177/13872877251365629.
BackgroundScreening for cognitive function, using tests such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), is the first step in detecting mild cognitive impairment (MCI) and dementia. However, the sensitivity of detecting MCI patients who will develop incident Alzheimer's disease (AD) dementia in the near future is low.ObjectiveThis study aimed to clarify the utility of the combination of the MMSE and MoCA in selecting patients at a high risk of incident AD dementia.MethodsIn this post-hoc analysis, we derived data from a Japanese observational registry of patients with vascular risk factors. The primary outcome was incident AD dementia. The accepted cutoff values of an MMSE score of 28 and an MoCA score of 26 for MCI were considered.ResultsAfter excluding those who did not undergo the test, 940 patients were included. During a median follow-up period of 4.6 years, incident AD dementia occurred in 49 patients. Patients diagnosed with MCI with MMSE scores <28 or MoCA scores <26 showed a significantly higher risk of AD dementia than those with normal MMSE or MoCA groups. However, patients who met the MCI criteria in only one test showed a risk similar to that of the normal group. In contrast, patients who met the MCI criteria for MMSE and MoCA scores had a 20.65-fold higher risk than those with normal MMSE and MoCA scores.ConclusionsPatients who met the MCI criteria for both the MMSE and MoCA were highly susceptible to incident AD dementia.Clinical Trial RegistrationUMIN000026671.
背景
使用简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)等测试对认知功能进行筛查,是检测轻度认知障碍(MCI)和痴呆症的第一步。然而,检测近期将发展为偶发性阿尔茨海默病(AD)痴呆症的MCI患者的敏感性较低。
目的
本研究旨在阐明MMSE和MoCA联合使用在筛选偶发性AD痴呆症高危患者中的效用。
方法
在这项事后分析中,我们从一个日本血管危险因素患者观察登记处获取数据。主要结局是偶发性AD痴呆症。考虑了MCI的MMSE评分28分和MoCA评分26分的公认临界值。
结果
排除未进行测试的患者后,纳入940例患者。在中位随访期4.6年期间,49例患者发生了偶发性AD痴呆症。MMSE评分<28或MoCA评分<26被诊断为MCI的患者发生AD痴呆症的风险显著高于MMSE或MoCA正常组的患者。然而,仅在一项测试中符合MCI标准的患者显示出与正常组相似的风险。相比之下,MMSE和MoCA评分均符合MCI标准的患者发生AD痴呆症的风险比MMSE和MoCA评分正常的患者高20.65倍。
结论
MMSE和MoCA均符合MCI标准的患者极易发生偶发性AD痴呆症。
临床试验注册
UMIN000026671